Terms: = Pancreatic cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
158 results:
1. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract] [Full Text] [Related]
2. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
3. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review.
Regalla DKR; Deep O; Paluri RK
Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer.
Lin X; Tan Y; Pan L; Tian Z; Lin L; Su M; Ou G; Chen Y
Cancer Chemother Pharmacol; 2024 Mar; 93(3):237-251. PubMed ID: 38040978
[TBL] [Abstract] [Full Text] [Related]
5. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
6. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
[TBL] [Abstract] [Full Text] [Related]
7. AKT and mtor expression in human pancreatic ductal adenocarcinoma. Relevance for tumor biology.
Handra-Luca A
Pathol Res Pract; 2023 Nov; 251():154878. PubMed ID: 37890271
[TBL] [Abstract] [Full Text] [Related]
8. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
9. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mtor signaling pathway.
Lin M; Xiao Y; Dai Y; Mao Y; Xu L; Zhang Q; Chen Z
Clin Transl Oncol; 2024 Apr; 26(4):951-965. PubMed ID: 37848695
[TBL] [Abstract] [Full Text] [Related]
10. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
11. Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors.
Chen Y; Yamamoto T; Takahashi Y; Moro T; Tajima T; Sakaguchi Y; Sakata N; Yokoyama A; Hijioka S; Sada A; Tabata Y; Ohki R
Cell Death Dis; 2023 Sep; 14(9):597. PubMed ID: 37679316
[TBL] [Abstract] [Full Text] [Related]
12. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAmtor2-mediated mtor activation.
Xu J; Quan G; Huang W; Jiang J
Cell Commun Signal; 2023 Aug; 21(1):223. PubMed ID: 37626304
[TBL] [Abstract] [Full Text] [Related]
13. Piper longum Constituents Induce PANC-1 Human pancreatic cancer Cell Death under Nutrition Starvation.
Fujihashi Y; Jo Kim M; Maneenet J; Awale S
Chem Biodivers; 2023 Sep; 20(9):e202300280. PubMed ID: 37612242
[TBL] [Abstract] [Full Text] [Related]
14. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target.
Yun WJ; Zhang L; Yang N; Cui ZG; Jiang HM; Ha MW; Yu DY; Zhao MZ; Zheng HC
Drug Dev Res; 2023 Nov; 84(7):1537-1552. PubMed ID: 37571819
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptome data-based status of PI3K/AKT/mtor pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma.
Xie P; Tan SY; Li HF; Tang HD; Zhou JH
J Gene Med; 2024 Jan; 26(1):e3570. PubMed ID: 37482968
[TBL] [Abstract] [Full Text] [Related]
16. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract] [Full Text] [Related]
17. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mtor complex 1 signalling pathway.
Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
[TBL] [Abstract] [Full Text] [Related]
18. SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mtor/4EBP1 pathway.
Wang H; Chen M; Yang C; Hu H; Jiang Y; Yang F; Lv L
Arch Biochem Biophys; 2023 Jul; 743():109661. PubMed ID: 37268273
[TBL] [Abstract] [Full Text] [Related]
19. MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes pancreatic Neuroendocrine Tumor Progression.
Xu J; Ye Z; Zhuo Q; Gao H; Qin Y; Lou X; Zhang W; Wang F; Wang Y; Jing D; Fan G; Zhang Y; Chen X; Chen J; Xu X; Yu X; Ji S
Cancer Res; 2023 Jul; 83(13):2226-2247. PubMed ID: 36939378
[TBL] [Abstract] [Full Text] [Related]
20. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mtor pathway.
Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z
Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796
[TBL] [Abstract] [Full Text] [Related]
[Next]